PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22869096-0	2012	The response to PAK1 inhibitor IPA3 distinguishes between cancer cells with mutations in BRAF and Ras oncogenes.	1-isopropyldiazen-1-ium-1,2-diolate	31-35	B-Raf proto-oncogene, serine/threonine kinase	Homo sapiens	89-93	
22869096-4	2012	We have tested a battery of melanoma and colon carcinoma cell lines that carry mutations in BRAF, NRAS and KRAS genes and have observed that those with NRAS and KRAS mutations are more sensitive to killing by IPA3.	1-isopropyldiazen-1-ium-1,2-diolate	209-213	B-Raf proto-oncogene, serine/threonine kinase	Homo sapiens	92-96